4.2 Article

Association analysis of myosin IXB and type 1 diabetes

期刊

HUMAN IMMUNOLOGY
卷 71, 期 6, 页码 598-601

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.humimm.2010.03.002

关键词

Diabetes; MYO9B; Genetics; Immunity; Celiac disease; Intestinal permeability

资金

  1. Medical UK Research Council
  2. British Society for Paediatric Endocrinology and Diabetes
  3. Wellcome Trust
  4. Juvenile Diabetes Research Foundation (JDRF), International
  5. Dutch Digestive Disease Foundation [97-44, 03-06]
  6. National Institute for Health Research Cambridge Biomedical Research Centre
  7. Dutch Diabetes Research Foundation [2008.40.001]
  8. Netherlands Organization for Health Research and Development (ZonMw) [016.096.121]
  9. Medical Research Council [G0000934] Funding Source: researchfish
  10. National Institute for Health Research [NF-SI-0508-10275] Funding Source: researchfish
  11. MRC [G0000934] Funding Source: UKRI

向作者/读者索取更多资源

To date, seven studies have provided evidence for an association between the gene encoding for myosin IXB (MYO9B) and celiac disease (CD), and inflammatory bowel diseases, including single nucleotide polymorphisms (SNPs) rs2305767, rs1457092, and rs2305764. We investigated whether MYO9B is associated with T1D. The three SNPs were genotyped in Dutch samples from 288 T1D patients and 1615 controls. The A allele of SNP rs2305767A>G showed some evidence of association with T1D (nominal p for genotype = 0.06; OR carrier = 1.51,95% CI = 1.04-2.19), but not in British samples from 4301 case patients and 4706 controls (p = 0.53), or when the Dutch and UK data were pooled (N patients = 4582, N controls = 6224; Mantel-Hansel p=0.83). Furthermore, the nonsynonymous rs1545620 C>A SNP that has been associated with the inflammatory bowel disease, showed no association with T1D in British case-control set (p = 0.57). We conclude that MYO9B might not be a strong determinant of T1D, although there was some association in our initial Dutch study. Further studies are needed to evaluate the role of MYO9B in T1D. (C) 2010 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

An integrative genomics approach identifies KDM4 as a modulator of trained immunity

Simone J. C. F. M. Moorlag, Vasiliki Matzaraki, Jelmer H. van Puffelen, Charlotte van der Heijden, Sam Keating, Laszlo Groh, Rutger Jan Roring, Olivier B. Bakker, Valerie A. C. M. Koeken, L. Charlotte J. de Bree, Sanne P. Smeekens, Marije Oosting, Raul Aguirre Gamboa, Niels P. Riksen, Ramnik J. Xavier, Cisca Wijmenga, Vinod Kumar, Reinout van Crevel, Boris Novakovic, Leo A. B. Joosten, Yang Li, Mihai G. Netea

Summary: Innate immune cells can develop memory characteristics through trained immunity. Host factors that affect the intensity of individual trained immunity responses are still largely unknown. This study identified key genes that influence trained immunity responses and highlighted the important roles of metabolic and epigenetic processes in regulating these responses.

EUROPEAN JOURNAL OF IMMUNOLOGY (2022)

Article Genetics & Heredity

Effect of host genetics on the gut microbiome in 7,738 participants of the Dutch Microbiome Project

Esteban A. Lopera-Maya, Alexander Kurilshikov, Adriaan van der Graaf, Shixian Hu, Sergio Andreu-Sanchez, Lianmin Chen, Arnau Vich Vila, Ranko Gacesa, Trishla Sinha, Valerie Collij, Marjiolein A. Y. Klaassen, Laura A. Bolte, Milla F. Brandao Gois, Pieter B. T. Neerincx, Morris A. Swertz, Hermie J. M. Harmsen, Cisca Wijmenga, Jingyuan Fu, Rinse K. Weersma, Alexandra Zhernakova, Serena Sanna

Summary: Host genetics influence the gut microbiome, with the LCT and ABO genes showing significant associations with microbial composition and function. The associations at the LCT locus are modulated by lactose intake, while those at ABO can be explained by participant secretor status determined by their FUT2 genotype. Further loci also show potential associations with microbial taxa and pathways. Larger sample sizes are needed to fully understand the effects of host genetics on the gut microbiome.

NATURE GENETICS (2022)

Article Hematology

A unique immune signature in blood separates therapy-refractory from therapy-responsive acute graft-versus-host disease

Astrid G. S. van Halteren, Jessica S. Suwandi, Sander Tuit, Jelske Borst, Sandra Laban, Roula Tsonaka, Ada Struijk, Anna-Sophia Wiekmeijer, Melissa van Pel, Bart O. Roep, Jaap Jan Zwaginga, Arjan C. Lankester, Koen Schepers, Maarten J. D. van Tol, Willem E. Fibbe

Summary: Acute graft-versus-host disease (aGVHD) is a potentially fatal complication of stem cell transplantation. This study used mass cytometry to analyze the immune cells in children with severe aGVHD and compared the results with control groups. The onset of aGVHD was associated with the appearance of specific myeloid and lymphoid cells in the blood and affected organs such as the skin and gastrointestinal tract. The findings highlight the importance of immune cell profiling for evaluating clinical response and managing severe aGVHD.
Article Multidisciplinary Sciences

Low risk for diabetic complications in type 1 diabetes patients carrying a protective insulin gene variant

Rene O. van Tienhoven, Anh Nguyet Vu, John Kaddis, Bart Roep

Summary: Type 1 diabetes patients carrying a protective insulin gene variant have reduced risk of proliferative diabetic retinopathy (PDR) and diabetic kidney disease (DKD) as long-term complications. The presence of this variant is associated with superior glycemic control and improved beta cell function. Intensive insulin therapy combined with this protective variant further decreases the risk of these complications.

PLOS ONE (2023)

Review Genetics & Heredity

iPSC-derived organ-on-a-chip models for personalized human genetics and pharmacogenomics studies

Victoria E. J. M. Palasantzas, Isabel Tamargo-Rubio, Kieu Le, Jelle Slager, Cisca Wijmenga, Iris H. Jonkers, Vinod Kumar, Jingyuan Fu, Sebo Withoff

Summary: Genome-wide association studies (GWAS) have identified numerous genetic variants associated with complex genetic diseases and drug efficacy. However, functional characterization of these variants is challenging due to the lack of human model systems. Organ-on-a-chip (OoC) platforms, enabled by advances in molecular and nanotechnology, provide personalized platforms for studying the impact of genetics and environment on organ physiology. This review highlights the technology and showcases the potential of OoCs in disease modeling and pharmacogenetic research.

TRENDS IN GENETICS (2023)

Article Immunology

The need and benefit of immune monitoring to define patient and disease heterogeneity, mechanisms of therapeutic action and efficacy of intervention therapy for precision medicine in type 1 diabetes

Bart O. Roep

Summary: The current standard of care for type 1 diabetes patients focuses on managing symptoms rather than addressing the underlying cause. Understanding the immunological aspects of the disease is crucial in order to develop effective treatments and personalize patient care. Immune monitoring provides valuable insights into disease progression, patient heterogeneity, and therapeutic responses, despite the associated challenges and costs. This perspective highlights the importance of immune monitoring in future trials and patient selection.

FRONTIERS IN IMMUNOLOGY (2023)

Article Endocrinology & Metabolism

Methylglyoxal products in pre-symptomatic type 1 diabetes

Sarah C. Shuck, Peter Achenbach, Bart O. Roep, John S. Termini, Carlos Hernandez-Castillo, Christiane Winkler, Andreas Weiss, Anette-Gabriele Ziegler

Summary: The study found that serum levels of MG-AGEs were associated with the rate of progression to stage 3 type 1 diabetes, with lower levels increasing the risk of progression. This provides a potential new clinical biomarker for determining the rate of disease progression and points to contributing metabolic pathways.

FRONTIERS IN ENDOCRINOLOGY (2023)

Article Endocrinology & Metabolism

Thrombospondin-1, CD47, and SIRPa display cell-specific molecular signatures in human islets and pancreata

Neslihan Erdem, Kuan-Tsen Chen, Meirigeng Qi, Yuqi Zhao, Xiwei Wu, Isaac Garcia, Hsun Teresa Ku, Enrique Montero, Ismail H. Al-Abdullah, Fouad Kandeel, Bart O. Roep, Jeffrey S. Isenberg

Summary: TSP1 is a secreted protein that is increased in disease and age. It binds to the cell receptor CD47 and creates a checkpoint for immune activation. Human islets express CD47 and secrete TSP1, but lack SIRPa. These findings are important for the use of CD47 and SIRPa blocking molecules in cancer patients.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2023)

Article Endocrinology & Metabolism

Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells

Rene van Tienhoven, Maria J. L. Kracht, Arno R. van der Slik, Sofia Thomaidou, Anouk H. G. Wolters, Ben N. G. Giepmans, Juan Pablo Romero Riojas, Michael S. Nelson, Francoise Carlotti, Eelco J. P. de Koning, Rob C. Hoeben, Arnaud Zaldumbide, Bart O. Roep

Summary: Transcriptome analysis identified insulin-gene-derived transcripts in non-beta endocrine islet cells. Researchers studied alternative splicing of human INS mRNA in pancreatic islets and found an alternatively spliced INS product that is expressed in delta cells but not in beta cells. This variant encodes the complete insulin signal peptide and B chain, and its presence in delta cells may play a role in islet autoimmunity and pathology.

DIABETOLOGIA (2023)

Article Medicine, General & Internal

Gene expression signature predicts rate of type 1 diabetes progression

Tomi Suomi, Inna Starskaia, Ubaid Ullah Kalim, Omid Rasool, Maria K. Jaakkola, Toni Gronroos, Tommi Valikangas, Caroline Brorsson, Gianluca Mazzoni, Sylvaine Bruggraber, Lut Overbergh, David Dunger, Mark Peakman, Piotr Chmura, Seren Brunak, Anke M. Schulte, Chantal Mathieu, Mikael Knip, Riitta Lahesmaa, Laura L. Elo

Summary: This study aimed to identify transcriptional changes associated with disease progression in patients with recent-onset type 1 diabetes. They found that genes and pathways related to innate immunity were downregulated during the first year after diagnosis. Associations between gene expression changes and ZnT8A autoantibody positivity were also observed. Additionally, changes in the expression of 16 genes were found to predict the decline in C-peptide at 24 months, and increased B cell levels and decreased neutrophil levels were associated with rapid progression, consistent with previous reports.

EBIOMEDICINE (2023)

Review Health Care Sciences & Services

The Progress and Pitfalls of Pharmacogenetics-Based Precision Medicine in Schizophrenia Spectrum Disorders: A Systematic Review and Meta-Analysis

Yuxin Teng, Amrit Sandhu, Edith J. J. Liemburg, Elnaz Naderi, Behrooz Z. Z. Alizadeh

Summary: This study reports the evidence for associations between pharmacogenetic variants and antipsychotics outcomes in patients with schizophrenia spectrum disorders. The findings suggest potential effects of certain genetic variants on antipsychotic response, weight gain, metabolic syndrome, prolactin levels, tardive dyskinesia, agranulocytosis, and drug concentration levels. However, further well-designed studies are needed to validate these findings.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Article Health Care Sciences & Services

Deep Clinical Phenotyping of Schizophrenia Spectrum Disorders Using Data-Driven Methods: Marching towards Precision Psychiatry

Tesfa Dejenie Habtewold, Jiasi Hao, Edith J. Liemburg, Nalan Basturk, Richard Bruggeman, Behrooz Z. Alizadeh

Summary: Heterogeneity poses a major challenge in the traditional classification of mental disorders, including schizophrenia spectrum disorders (SSD), due to the lack of objective diagnostic criteria. This article presents findings from the GROUP cohort study on the deep clinical phenotyping of SSD, focusing on positive and negative symptoms, cognitive impairments, and psychosocial functioning. Several latent subtypes of symptoms and cognitive impairments were identified in patients, siblings, and controls, while subtypes of psychosocial function were identified in patients. These findings are valuable for identifying high-risk groups and informing intervention selection in precision psychiatry.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Article Health Care Sciences & Services

Pharmacogenetics of Long-Term Outcomes of Schizophrenia Spectrum Disorders: The Functional Role of CYP2D6 and CYP2C19

Amrit K. Sandhu, Elnaz Naderi, Morenika J. Wijninga, Edith J. Liemburg, Danielle Cath, Richard Bruggeman, Behrooz Z. Alizadeh

Summary: This study aimed to investigate the association between genetic variation and long-term clinical outcomes in patients with schizophrenia spectrum disorders. The study found no association between PGx polygenic risk scores and clinical outcomes, but did find an association with CYP2D6 activity scores. These findings highlight the need to test PGx efficacy with different symptom domains.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Meeting Abstract Gastroenterology & Hepatology

Gut microbiome dysbiosis is associated with increased mortality following solid organ transplantation

Shixian Hu, J. Casper Swarte, Yanni Li, Johannes Bjork, Ranko Gacesa, Arnau Vich Vila, Rianne Douwes, Valerie Collij, Alexander Kurilshikov, Aadrian Post, Marjolein A. Y. Klaassen, Michele F. Eisenga, Antonio W. Gomes-Neto, Daan Kremer, Bernadien H. Jansen, Tim J. Knobbe, Stefan P. Berger, Jan-Stephan F. Sanders, M. Rebecca Heiner-Fokkema, Robert J. Porte, Frans J. C. Cuperus, Vincent E. Demeijer, Cisca Wijmenga, Eleonora A. M. Festen, Alexandra Zhernakova, Jingyuan Fu, Hermie J. M. Harmsen, Hans Blokzijl, Stephan J. L. Bakker, Rinse Weersma

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023)

暂无数据